therapy is required.98 This recommendation assumes
the use of newer generation drug-eluting stents in
patients with stable ischemic heart disease. Thus, percutaneous EVAR should be considered the operative
method of choice if aneurysm treatment becomes
necessary within 6 months after placement of a drugeluting stent as dual antiplatelet therapy can typically
be continued with use of this approach.
In summary, a recommendation for percutaneous or
surgical intervention for